NEW YORK (GenomeWeb) – The GenomeWeb Index fell nearly 1 percent in April, as disappointing preliminary earnings from Illumina and some concerns about whether Abbott would complete its acquisition of Alere dragged down the stocks of those firms.

The Dow Jones Industrial Average, which gained less than 1 percent during the month, and the Nasdaq Biotechnology Index, which gained 3 percent, outperformed the GenomeWeb Index. However, the Index outperformed the Nasdaq, which finished the month nearly 2 percent lower.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.